Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 1 , Pages 1-11, February 2010

Epidemiology of iodine deficiency: Salt iodisation and iodine status

  • Maria Andersson, MSc

      Affiliations

    • Human Nutrition Laboratory, Institute of Food Science and Nutrition, Swiss Federal Institute of Technology Zurich, Schmelzbergstrasse 7, CH 8092 Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 44 632 80 51; Fax: +41 44 632 1470.
  • ,
  • Bruno de Benoist, MSc, MD

      Affiliations

    • Route de Villars Dame, 1210 Versonnex, France
    • Tel.: +33 450 427929.
  • ,
  • Lisa Rogers, PhD

      Affiliations

    • Department of Nutrition for Health and Development, World Health Organization, CH 1211 Geneva 27, Switzerland
    • Tel.: +41 22 791 2111; Fax: +41 22 791 41 56.

Universal salt iodisation (USI) and iodine supplementation are highly effective strategies for preventing and controlling iodine deficiency. USI is now implemented in nearly all countries worldwide, and two-thirds of the world's population is covered by iodised salt. The number of countries with iodine deficiency as a national public health problem has decreased from 110 in 1993 to 47 in 2007. Still one-third of households lack access to adequately iodised salt. Iodine deficiency remains a major threat to the health and development of populations around the world, particularly in children and pregnant women in low-income countries. Data on iodine status are available from 130 countries and approximately one-third of the global population is estimated to have a low iodine intake based on urinary iodine (UI) concentrations. Insufficient control of iodine fortification levels has led to excessive iodine intakes in 34 countries. The challenges ahead lie in ensuring higher coverage of adequately iodised salt, strengthening regular monitoring of salt iodisation and iodine status in the population, together with targeted interventions for vulnerable population groups.

Keywords: iodine deficiency, iodised salt, monitoring, iodine status, urinary iodine, goitre, epidemiology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclaimer: One of the authors (LR) are staff members of the World Health Organization. They alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy or views of the World Health Organization.

PII: S1521-690X(09)00096-7

doi:10.1016/j.beem.2009.08.005

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 1 , Pages 1-11, February 2010